Flu Season Alert: December 22 H3N2 Surge Drives Healthcare Stocks

As the H3N2 flu cases rise sharply across Canada, the healthcare sector finds itself under significant scrutiny. With a positivity rate higher than in recent years, the focus on vaccinations has intensified. This surge not only impacts public health but also has potential implications for healthcare and biotech stocks. The increased strain on hospitals could translate into dynamic market activity, reshaping investor sentiment and opportunities.